Boston Scientific Corp. is taking a deeper dive into the mitral valve space with a $90 million investment and an acquisition option agreement with Millipede Medical Inc. The Santa Rosa, Calif.-based company has developed the Iris transcatheter annuloplasty ring system for the treatment of severe mitral regurgitation.